75 articles
A major study of 600,000 veterans finds GLP-1 weight loss drugs like Ozempic may reduce addiction risk and opioid overdose by up to 40%. New hope for addiction treatment.
Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...
Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...
Greg Pierce, SVP and GM of Specialty, Health & Wellness at Synchrony, a financial services company, discusses the over-the-counter (OTC) hearing aids ru...
Elizabeth Garner, MD, Chief Scientific Officer for Ferring Pharmaceuticals discusses C. Learn more on Health Professional Radio.
Medical Advisor, Drug Monitoring and Toxicology at Quest Diagnostics discusses a report that he co-authored that found that one in two patients (49%) sh...
Richard Browne, MD, FACC, Senior Medical Executive, Health Systems Strategy and the Leader of the Cardiovascular Health Equity Advisory Council for Jans...
Gregory Flesher is President and CEO of Reneo Pharmaceuticals, a clinical-stage pharmaceutical company tackling the significant unmet need of developing...
Returning guest, Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, a veteran of the industry and a developer of novel therapies that target...
Purvi Tailor, Vice President, Human Resources at Ferring Pharmaceuticals discusses the company's new family-building benefits package for all of its emp...